Objective: To assess perioperative complications and 90-day mortality of radical cystectomy (RC) in elderly patients with muscle-invasive bladder cancer (MIBC). Materials and Methods: This is a retrospective, multicentre (n = 11) study of a consecutive series of patients ≥75 years who underwent RC for MIBC between 2006 and 2010. Medical, surgical and wound complications were graded according to the modified Clavien-Dindo classification. Results: A total of 256 patients with a mean age of 79.6 years (range 75.0-86.6) were analysed. Urinary diversion with the use of bowel was performed in 79.5% and ureterocutaneostomy in 20.5%, with a higher proportion in the ≥80 cohort (32.2 vs. 14%; p = 0.001). 41.4% of patients had an uneventful postoperative course (Clavien grade 0) and 26.6% developed severe complications (Clavien grade III-V). In a multivariable regression analysis, the Charlson comorbidity index (odds ratio 1.5 per unit increase; p < 0.001) and the body mass index (odds ratio 1.13 per kg/m2 increase; p = 0.015) were predictors for the development of complications. The 90-day mortality rate was 9% and the independent correlates thereof were the development of severe medical complications (p = 0.004), the American Society of Anesthesiologists (ASA) score (p = 0.03) and age (p = 0.005). Conclusions: Morbidity and 90-day mortality of RC in the elderly remain substantial. The interrelation between comorbidity, complication rate and 90-day mortality underlines the need for a comprehensive geriatric assessment of elderly patients with MIBC in whom RC is indicated.

Keywords:
Radical cystectomy, Elderly, Complications, Clavien-Dindo classification, Charlson comorbidity index
1.
Ferlay J, Parkin DM, Steliarova-Foucher E: Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer 2010;46:765-781.
2.
Stenzl A, Witjes JA, Cowan NC, et al: Guidelines on bladder cancer: muscle invasive and metastatic. Guidelines of the European Association of Urology 2011 edition. www.eau.org.
3.
Shabsigh A, Korets R, Vora KC, et al: Defining early morbidity of radical cystectomy for patients with bladder cancer using a standardized reporting methodology. Eur Urol 2009;55:164-174.
4.
Konety BR, Allareddy V, Herr H: Complications after radical cystectomy: analysis of population based data. Urology 2006;68:58-64.
5.
Hollenbeck BK, Miller DC, Taub D, et al: Identifying risk factors for potentially avoidable complications following radical cystectomy. J Urol 2005;174:1231-1237.
6.
Konety BR, Joslyn SA: Factors influencing aggressive therapy for bladder cancer: an analysis of the SEER program. J Urol 2003;170:1765-1771.
7.
Schrag D, Mitra N, Xu F, et al: Cystectomy for muscle-invasive bladder cancer: patterns and outcomes of care in the Medicare population. Urology 2005;65:1118-1125.
8.
Prout GR Jr, Wesley MN, Yancik R, et al: Age and comorbidity impact surgical therapy in older bladder carcinoma patients: a population based study. Cancer 2005;104:1638-1647.
9.
Koppie TM, Serio AM, Vickers AJ, et al: Age-adjusted Charlson comorbidity score is associated with treatment decisions and clinical outcomes for patients undergoing radical cystectomy for bladder cancer. Cancer 2008;112:2384-2392.
10.
Hollenbeck BK, Miller DC, Taub D, et al: Aggressive treatment for bladder cancer is associated with improved overall survival among patients 80 years old or older. Urology 2004;64:292-297.
11.
Fairey A, Chetner M, Metcalfe J, et al: Associations among age, comorbidity and clinical outcomes after radical cystectomy: results from the Alberta Urology Institute radical cystectomy database. J Urol 2008;180:185-192.
12.
Novotny V, Hakenberg OW, Froehner M, et al: Systematic assessment of complications and outcome of radical cystectomy undertaken with curative intent in patients with comorbidity and over 75 years of age. Urol Int 2013;90:195-201.
13.
Froehner M, Brausi MA, Herr HW, et al: Complications following radical cystectomy for bladder cancer in the elderly. Eur Urol 2009;56:443-454.
14.
Clavien PA, Barkun J, de Oliveira ML, et al: The Clavien Dindo classification of surgical complications: five-year experience. Ann Surg 2009;250:187-196.
15.
Dindo D, Demartines N, Clavien PA: Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004;240:205-213.
16.
Chamie K, Hu B, Devere White RW, Ellison LM: Cystectomy in the elderly: does survival benefit in younger patients translate to the octogenarians? BJU Int 2008;102:284-290.
17.
Rassweiler JJ, Rassweiler MC, Michel MS: Classification of complications: is the Clavien-Dindo classification the gold standard? Eur Urol 2012;62:256-258; discussion 259-260.
18.
Mitropoulos D, Artibani W, Graefen M, et al: Reporting and grading of complications after urologic surgical procedures: an ad hoc EAU guidelines panel assessment and recommendations. Eur Urol 2012;61:341-349.
19.
Clark PE, Stein JP, Groshen SG, et al: Radical cystectomy in the elderly: comparison of clinical outcomes between younger and older patients. Cancer 2005;104:36-43.
20.
Donat SM, Siegrist T, Cronin A, et al: Radical cystectomy in octogenarians - does morbidity outweigh the potential survival benefits? J Urol 2010;183:2171-2177.
21.
Elting LS, Pettaway C, Bekele BN, et al: Correlation between annual volume of cystectomy, professional staffing and outcomes: a state-wide, population-based study. Cancer 2005;104:975-984.
22.
Konety BR, Dhawan V, Allareddy V, Joslyn SA: Impact of hospital and surgeon volume on in-hospital mortality from radical cystectomy: data from the Health Care Utilization Project (HCUP). J Urol 2005;173:1695-1700.
23.
Liberman D, Lughezzani G, Sun M, et al: Perioperative mortality is significantly greater in septuagenarian and octogenarian patients treated with radical cystectomy for urothelial carcinoma of the bladder. Urology 2011;77:660-666.
24.
Boorjian SA, Kim SP, Tollefson MK, et al: Comparative performance of comorbidity indices for estimating perioperative and 5-year all-cause mortality following radical cystectomy for bladder cancer. J Urol 2013;190:55-60.
25.
Lee CT, Dunn RL, Chen BT, et al: Impact of body mass index on radical cystectomy. J Urol 2004;172:1281-1285.
26.
Nielsen ME, Shariat SF, Karakiewicz PI, et al: Advanced age is associated with poorer bladder cancer-specific survival in patients treated with radical cystectomy. Eur Urol 2007;51:699-706.
27.
Mayr R, May M, Martini T, et al: Predictive capacity of four comorbidity indices estimating perioperative mortality after radical cystectomy for urothelial carcinoma of the bladder. BJU Int 2012;110:222-227.
28.
Dewan SK, Zheng SB, Xia SJ: Preoperative geriatric assessment: comprehensive, multidisciplinary and proactive. Eur J Intern Med 2012;23:487-494.
29.
Shariat SF, Karakiewicz PI, Palapattu GS, et al: Nomograms provide improved accuracy for predicting survival after radical cystectomy. Clin Cancer Res 2006;12:6663-6676.
© 2014 S. Karger AG, Basel
2014
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.